Back

Impact of Age on Heroin Intravenous Self-Administration in Wistar Rats

Taffe, M. A.; Mehl, S. L.; Grant, Y.; Vandewater, S. A.

2026-05-10 pharmacology and toxicology
10.64898/2026.05.05.723054 bioRxiv
Show abstract

BackgroundEvidence suggests steeper accelerating opioid-related overdose, and non-medical use rates, in middle aged men in recent years compared with younger cohorts. Little is known about whether this is driven by age-related differences in the effects of opioids compared with socio-cultural factors driving non-medical consumption. Rodent models can be useful for dissociating biological from psychosocial factors, however, only minimal evidence exists on the effects of opioids in middle-age rats. ObjectiveTo determine if the anti-nociceptive and rewarding effects of opioids differ between adult and middle-age rats. MethodsFemale and male Wistar rats were obtained in early adulthood and examined across 4 to 11 months of age for nociceptive responses to heroin (0-1.56 mg/kg, s.c.) using a warm-water tail withdrawal assay. Subgroups (N=8 per group) were initiated on intravenous self-administration (IVSA) of heroin at either 5 months or 12 months of age. ResultsAnti-nociceptive effects of heroin did not differ across age. Female rats that initiated IVSA in early adulthood or middle-age obtained significantly more infusions of heroin than male rats of the same age during acquisition, and in dose-substitution under a FR1 schedule. Male, but not female, rats that initiated IVSA in middle age self-administered less heroin then rats that initiated in early adulthood; this was observed in acquisition and in dose-substitution. DiscussionThis study shows that opioid reward is diminished in middle aged male rats. It also found that middle age rats can be used effectively to model opioid-related outcomes, including drug seeking using the IVSA procedure.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
Drug and Alcohol Dependence
37 papers in training set
Top 0.1%
40.9%
2
Psychopharmacology
59 papers in training set
Top 0.1%
13.0%
50% of probability mass above
3
PLOS ONE
4510 papers in training set
Top 24%
7.1%
4
Pharmacology Biochemistry and Behavior
17 papers in training set
Top 0.1%
6.6%
5
Neuropharmacology
60 papers in training set
Top 0.2%
3.7%
6
Scientific Reports
3102 papers in training set
Top 44%
2.7%
7
Journal of Psychopharmacology
14 papers in training set
Top 0.2%
2.2%
8
Frontiers in Pharmacology
100 papers in training set
Top 1%
2.2%
9
British Journal of Pharmacology
34 papers in training set
Top 0.2%
2.0%
10
Frontiers in Psychiatry
83 papers in training set
Top 2%
1.8%
11
Neuropsychopharmacology
134 papers in training set
Top 2%
1.7%
12
ACS Pharmacology & Translational Science
40 papers in training set
Top 0.4%
1.5%
13
The Journal of Pharmacology and Experimental Therapeutics
15 papers in training set
Top 0.2%
1.3%
14
European Journal of Neuroscience
168 papers in training set
Top 1%
0.9%
15
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 1%
0.8%
16
International Journal of Neuropsychopharmacology
11 papers in training set
Top 0.2%
0.8%
17
Journal of Psychiatric Research
28 papers in training set
Top 0.7%
0.8%
18
Journal of Neuroscience Methods
106 papers in training set
Top 2%
0.8%
19
Behavioral Neuroscience
25 papers in training set
Top 0.3%
0.8%
20
Biomedicines
66 papers in training set
Top 3%
0.8%
21
Brain Sciences
52 papers in training set
Top 2%
0.8%